TERAPIA CELULAR-GÉNICA
Terapia Génica y Celular
Publications (60) Publications auxquelles un chercheur a participé
2024
-
Application of Genomic Medicine in Africa: 14th Conference of the African Society of Human Genetics and the 2nd International Congress of the Moroccan Society of Genomics and Human Genetics, Rabat, Morocco 2022
American Journal of Tropical Medicine and Hygiene, Vol. 110, Núm. 6, pp. 1279-1284
-
Autologous patient-derived exhausted nano T-cells exploit tumor immune evasion to engage an effective cancer therapy
Molecular Cancer, Vol. 23, Núm. 1
-
Generating universal anti-CD19 CAR T cells with a defined memory phenotype by CRISPR/Cas9 editing and safety evaluation of the transcriptome
Frontiers in Immunology, Vol. 15
2023
-
Abrogation of stemness in osteosarcoma by the mithramycin analog EC-8042 is mediated by its ability to inhibit NOTCH-1 signaling
Biomedicine and Pharmacotherapy, Vol. 162
-
Estradiol and Estrone Have Different Biological Functions to Induce NF-κB-Driven Inflammation, EMT and Stemness in ER+ Cancer Cells
International Journal of Molecular Sciences, Vol. 24, Núm. 2
-
Failure of ALL recognition by CAR T cells: a review of CD 19-negative relapses after anti-CD 19 CAR-T treatment in B-ALL
Frontiers in immunology, Vol. 14, pp. 1165870
-
High-Density Lipoprotein in Metabolic Disorders and Beyond: An Exciting New World Full of Challenges and Opportunities
Pharmaceuticals, Vol. 16, Núm. 6
-
LRRK2 Knockout Confers Resistance in HEK-293 Cells to Rotenone-Induced Oxidative Stress, Mitochondrial Damage, and Apoptosis
International Journal of Molecular Sciences, Vol. 24, Núm. 13
-
Lentiviral gene therapy reverts GPIX expression and phenotype in Bernard-Soulier syndrome type C
Molecular Therapy - Nucleic Acids, Vol. 33, pp. 75-92
-
Lentiviral vectors for inducible, transactivator-free advanced therapy medicinal products: Application to CAR-T cells
Molecular Therapy - Nucleic Acids, Vol. 32, pp. 322-339
-
Preclinical Evidence for the Use of Oral Mesenchymal Stem Cell-Derived Extracellular Vesicles in Bone Regenerative Therapy: A Systematic Review
Stem Cells Translational Medicine, Vol. 12, Núm. 12, pp. 791-800
-
Progress and harmonization of gene editing to treat human diseases: Proceeding of COST Action CA21113 GenE-HumDi
Molecular Therapy Nucleic Acids, Vol. 34
-
Reductive carboxylation epigenetically instructs T cell differentiation
Nature, Vol. 621, Núm. 7980, pp. 849-856
-
Role of Hospital Exemption in Europe: position paper from the Spanish Advanced Therapy Network (TERAV)
Bone Marrow Transplantation
-
The Black Hole: CAR T Cell Therapy in AML
Cancers, Vol. 15, Núm. 10
2022
-
Editorial: Engineered immune cells in cancer immunotherapy (EICCI)
Frontiers in Immunology
-
Efficacy and safety of universal (TCRKO) ARI-0001 CAR-T cells for the treatment of B-cell lymphoma
Frontiers in Immunology, Vol. 13
-
Erratum: Physiological lentiviral vectors for the generation of improved CAR-T cells (Molecular Therapy - Oncolytics (2022) 25 (335–349), (S2372770522000687), (10.1016/j.omto.2022.05.003))
Molecular Therapy - Oncolytics
-
Genetic engineering of autologous or allogeneic immune effector cells
The EBMT/EHA CAR-T Cell Handbook (Springer International Publishing), pp. 7-10
-
Isogenic GAA-KO Murine Muscle Cell Lines Mimicking Severe Pompe Mutations as Preclinical Models for the Screening of Potential Gene Therapy Strategies
International Journal of Molecular Sciences, Vol. 23, Núm. 11